"Injections, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Injections made into a vein for therapeutic or experimental purposes.
Descriptor ID |
D007275
|
MeSH Number(s) |
E02.319.267.082.750 E02.319.267.530.540
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Injections, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Injections, Intravenous".
This graph shows the total number of publications written about "Injections, Intravenous" by people in this website by year, and whether "Injections, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
2005 | 0 | 2 | 2 |
2006 | 0 | 2 | 2 |
2007 | 0 | 1 | 1 |
2010 | 0 | 2 | 2 |
2012 | 0 | 1 | 1 |
2014 | 0 | 3 | 3 |
2016 | 0 | 1 | 1 |
2017 | 0 | 24 | 24 |
2018 | 2 | 22 | 24 |
2019 | 0 | 7 | 7 |
2020 | 0 | 4 | 4 |
2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Injections, Intravenous" by people in Profiles.
-
Nanoparticle-mediated surfactant therapy in patients with severe COVID-19: a perspective. J Mater Chem B. 2021 09 15; 9(35):6988-6993.
-
Metoprolol in Critically Ill Patients With COVID-19. J Am Coll Cardiol. 2021 09 07; 78(10):1001-1011.
-
Oral administration of methylprednisolone powder for intravenous injection dissolved in water to treat MS and NMOSD relapses during COVID-19 pandemic in a real-world setting. Mult Scler Relat Disord. 2021 Sep; 54:103148.
-
Identification of the absorbed ingredients and metabolites in rats after an intravenous administration of Tanreqing injection using high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J Sep Sci. 2021 May; 44(10):2097-2112.
-
Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients. 2021 Mar 31; 13(4).
-
A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients. J Med Virol. 2021 May; 93(5):3261-3267.
-
Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia. J Allergy Clin Immunol. 2021 04; 147(4):1217-1225.
-
Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial. Trials. 2021 Jan 20; 22(1):71.
-
Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study. Nutrients. 2021 Jan 14; 13(1).
-
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials. 2021 Jan 04; 22(1):1.